Egyéb betegségekre

i Fachet József: Immunválaszok genetikai szabályozása és modulációja polysaccharidákkal: Tumor immunotherápiás és immun-biotechnológiai vonatkozások; Debrecen, 1993. MTA, Doktori Értekezés Tézisei

ii lásd uo.

iii Fachet et al.: Modulation of immune responses and defense against tumor by a polymannan-polyglycan polysaccharide; Mannozym; Int.J.Immunopharmacol. 1980; 2, 185.

iv Lapis, K. et al.: Experimental metastasis inhibition by pretreatment of the host; In: Arch Geschwulstforsch., 1990; 60(2): 97-102.

v Ladanyi, A., Timar, J., Lapis, K.: Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells; In: Cancer Immunol Immunother, 1993; 36(2): 123-6.

vi Zákány, J. et al.: Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts; Int. J. Cancer; 1980, 25, 371-376.

vii Suga et al.: Effect of lentinan against allogeneic, syngeneic and autologous primary tumours and its prophylactic effect on chemical carcinogenesis; In: Manipulation of Host defence Mechanism III. Eds. Aoki et al.: Excepta Medica; 1985, 116-128.

viii Fachet,J: Effects of mannozym, a polyglucan-polymannan, on different immune responses and resistanse to tumor; In: Adv. in Immunopharmacology. Ed. By Hadden et al. Pergamon Press, 1981. 483.

ix Fachet, J: A szervezet endokrin és immunvédekező rendszerei; Orvostudomány, 1982, 33, 261-274.

x Zákány, J. et al: Mechanism of the AIPh.MCS1 tumor graft rejection in syngeneic mice; Gann. 1983, 74, 712-722

xi Suga et al.: Effect of lentinan against allogeneic, syngeneic and autologous primary tumours and its prophylactic effect on chemical carcinogenesis; In: Manipulation of Host defence Mechanism III. Eds. Aoki at al.: Excepta Medica; 1985, 116-128.

xii Fachet József: Immunválaszok genetikai szabályozása és modulációja polysaccharidákkal: Tumor immunotherápiás és immun-biotechnológiai vonatkozások; Debrecen, 1993. MTA, Doktori Értekezés Tézisei

xiii uo.

xiv Sipka, S. et al.: Effect of lentinan on the chemiluminescence produced by human neutrophils and the murine macrophage cell line C4MΦ; Int.J. Immunopharmacol., 1985,7, 747-751.

xv Ábel Gy.et al: Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: A flow cytometric study; Int.J.Immunopharmacology; 1989, 11, 615-621.

xvi Ábel Gy.et al.: Effect of lentinan on pinocytosis in mouse peritoneal macrophages and the murine macrophage cell line C4MI in vitro; Int.J.Immunopharmac,1986, 8, 919-924.

xvii Kerékgyártó, Cs.et al.: Strain differences in the cytotoxic activity and TNF production of murine macrophages stimulated by lentinan; Int.J.Immunopharmacology, 1996, 18, 347-353.

xviii Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.

xix Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.

xx Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.

xxi Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.

xxii Fachet et al.: Effect of lentinan on different types of immune responses including anaphylactic shock; In: „Host defense mechanisms against cancer”, Proc. of 7th Symp. on host defense mechanism against cancer, Hakone, Japan, 1985. nov. 8-10. Excerpta Medica; 1986, 183-194.

xxiii Zákány, J. et al.: Effect of lentinan on the production of migration inhibitory factor (MIF) induced by syngeneic tumor in mice; Int. J. Cancer, 1980, 26, 783-788.

xxiv Kerékgyártó, Cs.et al.: Strain differences in the cytotoxic activity and TNF production of murine macrophages stimulated by lentinan; Int.J.Immunopharmacology, 1996, 18, 347-353.

xxv Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.

xxvi Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.

xxvii Fachet József: Immunválaszok genetikai szabályozása és modulációja polysaccharidákkal: Tumor immunotherápiás és immun-biotechnológiai vonatkozások; Debrecen, 1993. MTA, Doktori Értekezés Tézisei

xxviii Kodama, N.et al.: Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice; In:J Med Food, 2004, 7(2):141-5.

xxix el-Mekkawy, S. et al.: Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum; In:Phytochemistry, 1998, 49(6):1651-7.

xxx Min, BS. et al.: Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease; In: Chem Pharm Bull (Tokyo), 1998, 46(10):1607-12.

xxxi Szakirodalmi adatokat a tumorellenes hatás tekintetében lásd később a részletes összefoglalókban.

xxxii Bernardshaw, S. et al.: An extract f the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice; In: Scand J Immunol. 2005, 62(4): 393-8.

xxxiii Eo, SK. et al.: Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum; In: J. Ethnopharmacol. 1999, 68(1-3): 129-136.

xxxiv Horio, H. et al.: Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats; In: J Nutr Sci Vitaminol (Tokyo), 2001, 47(1): 57-63.

xxxv Kubo, K. et al.: Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake).I.; In: Biol Pharm Bull, 1994, 17(8):1106-10.

xxxvi Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.

xxxvii Hikino, H. et al.: Mechanism of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies; In: Panta Med., 1989, 55(5):423-8.

xxxviii Zhang, H. et al.: Hypoglycemic effect of Ganoderma lucidum polysaccharides; In: Acta Pharmacol Sin, 2004, 25(2): 191-195.

xxxix Zhang, HN. et al.: In vitro and in vivo protective effect of Ganoderma lucidum polyaccharides on alloxan-induced pancreatic islets damage; In: Life Sci. 2003, 73(18):2307-19.

xl Lee, SY. et al.: Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action; In: Chem Pharm Bull (Tokyo).,1990, 38(5): 1359-64.

xli Kabir, Y. et al.: Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats; In: J Nutr Sci Vitaminol (Tokyo), 1987, 33(5): 341-6.

xlii Tasaka, K. et al.: Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release; In: Agent Actions, 1988, 23(3-4):157-60.

xliii Berger, A.et al.: Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs; In: Lipids Health Dis., 2004,18;3:2.

xliv Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.

xlv Komoda, Y. et al.: Ganoderic acid and its derivatives as cholesterol synthesis inhibitors; In: Chem Pharm Bull (Tokyo)., 1989, 37(2): 531-3.

xlvi Fukushima, M. et al.: Cholesterol-Lowering Effects of Maitake…In: Exp Biol Med., 2001, 226(8): 758-765.

xlvii Hajjaj, H. et al.: Effect of 26-Oxygenosterols from Ganoderma lucidum and Their Activity as Cholesterol Synthesis Inhibitors; In: Applied and Enviromental Microbiology, 2005, July, p. 3653-3658.

xlviii Kubo, K. et al.: Anti-hyperliposis effect of maitake fruit body (Grifola frondosa).I.; In: Biol Pharm Bull., 1997, 20(7): 781-5.

xlix Kabir, Y. et al.: Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on blood pressure and plasma lipids of spontaneously hypertensive rats; In: J Nutr Sci Vitaminol (Tokyo), 1987, 33(5): 341-6.

l Ren, LK. et al.: Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation); In: Vopr Pitan, 1989,(1):16-9.

li Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.

lii Tao, J. et al.: Experimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet aggregation; In: J Tongji Med Univ, 1990, 10(4): 240-3.

liii Lin, H. et al.: Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro; In: Int Immunopharmacol., 2004, 4(1): 91-9.

liv Zhao, H. et al.: Polysaccharide Extract Isolated From Ganoderma lucidum Protects Rat Cerebral Cortical Neurons From Hypoxia/Reoxygenation Injury; In: J. Pharmacol Sci. 2004, 95, 294-288.

lv Nishina, A. et al.: Lysophosphatidy lethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAP kinase; In: J Lipid Res. 2006, Apr. 13.

lvi uo.

lvii Zhu, WW. et al.: Effect of the oil from ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice; In: Di Yi Jun Da Xue Xue Bao, 2005, 25(6):667-71.

lviii Tang, W. et al: A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia; In: J. Med Food, 2005, 8(1):53-8.

lix Shieh, YH. et al.: Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice; In: Am J Chin Med., 2001, 29 (3-4): 501-7.

lx Li, Y. et al.: Anti-hepatitis Activities in the Broth of Ganoderma lucidum…; In:Am J Chin Med., 2006, 34(2): 341-9.

lxi Yang, XJ. et al.: In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury; In: World J Gastroenterol., 200